Evidence map›Paper›PMID 26226598›Full record

ArticleThe Journal of infection2015

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.

Jay Lucidarme, Dorothea M C Hill, Holly B Bratcher, Steve J Gray, Mignon du Plessis, Raymond S W Tsang, Julio A Vazquez, Muhamed-Kheir Taha, Mehmet Ceyhan, Adriana M Efron and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
22.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Rapid and recent evolution ofMicrobial genomics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Genomic analysis ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Epidemiology and genetic diversity of invasive Neisseria meningitidis strains circulating in Portugal from 2003 to 2020.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  15. A speed limit on serial strain replacement from original antigenic sin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. A speed limit on serial strain replacement from original antigenic sin.bioRxiv : the preprint server for biology · 2024
    Article
  18. Classification ofiScience · 2024
    Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 8 countries.

Jay LucidarmeVaccine Evaluation Unit, Public Health England, Manchester Medical Microbiology Partnership, Second Floor, Clinical Sciences Building II, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WZ, UK. Electronic address: jay.lucidarme@phe.gov.uk.
Dorothea M C HillDepartment of Zoology, University of Oxford, Oxford, UK. Electronic address: dorothea.hill@zoo.ox.ac.uk.
Holly B BratcherDepartment of Zoology, University of Oxford, Oxford, UK. Electronic address: holly.bratcher@zoo.ox.ac.uk.
Steve J GrayMeningococcal Reference Unit, Public Health England, Manchester Medical Microbiology Partnership, Second Floor, Clinical Sciences Building II, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WZ, UK. Electronic address: Steve.Gray@phe.gov.uk.
Mignon du PlessisCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, National Health Laboratory Service, 1 Modderfontein Road, Sandringham, Johannesburg, 2131, South Africa. Electronic address: mignond@nicd.ac.za.
Raymond S W TsangNational Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB R3E 3R2, Canada. Electronic address: Raymond.Tsang@phac-aspc.gc.ca.
Julio A VazquezReference Laboratory for Meningococci, Institute of Health Carlos III, Majadahonda, Spain. Electronic address: julioavazquez@gmail.com.
Muhamed-Kheir TahaInstitut Pasteur, Unité des Infections Bactériennes invasives, Département Infection et Epidémiologie, Paris, France. Electronic address: muhamed-kheir.taha@pasteur.fr.
Mehmet CeyhanFaculty of Medicine, Hacettepe University, Ankara, Turkey. Electronic address: mceyhan@hacettepe.edu.tr.
Adriana M EfronServicio Bacteriología Clínica, Departamento de Bacteriología, Instituto Nacional de Enfermedades Infecciosas-ANLIS «Dr. Carlos G. Malbrán», Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: amefron@anlis.gov.ar.
Maria C GorlaDivision of Medical Biology, Bacteriology Department, Adolfo Lutz Institute, São Paulo 01246-902, Brazil. Electronic address: mcgorla@ial.sp.gov.br.
Jamie FindlowVaccine Evaluation Unit, Public Health England, Manchester Medical Microbiology Partnership, Second Floor, Clinical Sciences Building II, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WZ, UK. Electronic address: Jamie.Findlow@phe.gov.uk.
Keith A JolleyDepartment of Zoology, University of Oxford, Oxford, UK. Electronic address: keith.jolley@zoo.ox.ac.uk.
Martin C J MaidenDepartment of Zoology, University of Oxford, Oxford, UK. Electronic address: martin.maiden@zoo.ox.ac.uk.
Ray BorrowVaccine Evaluation Unit, Public Health England, Manchester Medical Microbiology Partnership, Second Floor, Clinical Sciences Building II, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WZ, UK; Meningococcal Reference Unit, Public Health England, Manchester Medical Microbiology Partnership, Second Floor, Clinical Sciences Building II, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WZ, UK. Electronic address: Ray.Borrow@phe.gov.uk.
University of Oxford · GBPublic Health England · GBAdministración Nacional de Laboratorios e Institutos de Salud · ARHacettepe University · TRInstituto Adolfo Lutz · BRInstituto de Salud Carlos III · ESInstitut Pasteur · FRManchester Royal Infirmary · GBNational Health Laboratory Service · ZAPublic Health Agency of Canada · CA

Funding

Wellcome Trust 087622
6 · The paper itself

Abstract

objectivesNeisseria meningitidis is a leading cause of meningitis and septicaemia. The hyperinvasive ST-11 clonal complex (cc11) caused serogroup C (MenC) outbreaks in the US military in the 1960s and UK universities in the 1990s, a global Hajj-associated serogroup W (MenW) outbreak in 2000-2001, and subsequent MenW epidemics in sub-Saharan Africa. More recently, endemic MenW disease has expanded in South Africa, South America and the UK, and MenC cases have been reported among European and North American men who have sex with men (MSM). Routine typing schemes poorly resolve cc11 so we established the population structure at genomic resolution.

methodsRepresentatives of these episodes and other geo-temporally diverse cc11 meningococci (n = 750) were compared across 1546 core genes and visualised on phylogenetic networks.

resultsMenW isolates were confined to a distal portion of one of two main lineages with MenB and MenC isolates interspersed elsewhere. An expanding South American/UK MenW strain was distinct from the 'Hajj outbreak' strain and a closely related endemic South African strain. Recent MenC isolates from MSM in France and the UK were closely related but distinct.

conclusionsHigh resolution 'genomic' multilocus sequence typing is necessary to resolve and monitor the spread of diverse cc11 lineages globally.

Indexed as

Multilocus Sequence TypingDisease OutbreaksEndemic DiseasesFranceHomosexuality, MaleHumansMaleMeningococcal InfectionsNeisseria meningitidisNeisseria meningitidis, Serogroup BNeisseria meningitidis, Serogroup CNorth AmericaPhylogenySerogroupSerotypingSouth AfricaGenomeMeningococcalSerogroup CSerogroup WST-11 clonal complex

Identifiers

PMID26226598
PMCPMC4635312
OpenAlexW2162434670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.